Wave Life Sciences Ltd (WVE)

Jul 11, 2026

WVE Technical Analysis & Stock Price Forecast - Intellectia AI

Jul 11, 2026

Jul 10, 2026

ARWR Stock Slid Lower Today — What Does Wave Life Sciences Have To Do With It? - Stocktwits

Jul 10, 2026

Jul 09, 2026

Has Wave Life Sciences (WVE) Fallen Far Enough To Look Fairly Valued? - simplywall.st

Jul 09, 2026

Jul 08, 2026

Wave Life Sciences (WVE) Jefferies London Healthcare Conference 2025 Summary - Quartr

Jul 08, 2026

Jul 07, 2026

Wave Life Sciences court hearing set for July 14 on redomiciliation - Investing.com

Jul 07, 2026

Jul 07, 2026

Wave Life Sciences court hearing set for July 14 on redomiciliation By Investing.com - Investing.com South Africa

Jul 07, 2026

Jul 07, 2026

Wave Life Sciences Announces Singapore Court Hearing, to be held on July 14, 2026 to Approve Scheme of Arrangement for Redomiciliation - The Manila Times

Jul 07, 2026

Jul 06, 2026

What Went Wrong For WVE? The Obesity Drug Trial Data That Spooked Investors - Stocktwits

Jul 06, 2026

Jul 05, 2026

Wave Life Sciences (WVE) Is Up 7.4% After Advancing RNA-Based Obesity Drug Into Phase 2a Trial - simplywall.st

Jul 05, 2026

Jul 02, 2026

Is Wave Life Sciences (WVE) Undervalued On Its New Obesity Trial Progress? - simplywall.st

Jul 02, 2026

Jul 01, 2026

Does Wave Life Sciences (WVE) Have the Potential to Rally 294.66% as Wall Street Analysts Expect? - Yahoo Finance

Jul 01, 2026

Jul 01, 2026

Jessica Chen - White & Case LLP

Jul 01, 2026

Jun 30, 2026

(WVE) Volatility Zones as Tactical Triggers - Stock Traders Daily

Jun 30, 2026

Jun 30, 2026

Wave Life Sciences (WVE) Initiates Multidose Phase 2a for INLIGHTTM Trial - Insider Monkey

Jun 30, 2026

Jun 28, 2026

Price to earnings forward of Wave Life Sciences Ltd. – NASDAQ:WVE - TradingView

Jun 28, 2026

Jun 28, 2026

7 Singapore Companies That Have Listed On Nasdaq And Where They Are Now - DollarsAndSense.sg

Jun 28, 2026

Jun 27, 2026

Does Wave Life Sciences’ (WVE) RNA Obesity Program Signal a Shift in Its Competitive Positioning? - simplywall.st

Jun 27, 2026

Jun 27, 2026

Enterprise value to EBITDA forward of Wave Life Sciences Ltd. – NASDAQ:WVE - TradingView

Jun 27, 2026

Jun 27, 2026

Price to sales forward of Wave Life Sciences Ltd. – NASDAQ:WVE - TradingView

Jun 27, 2026

Jun 26, 2026

Enterprise value to EBIT forward of Wave Life Sciences Ltd. – NASDAQ:WVE - TradingView

Jun 26, 2026

Jun 26, 2026

Price to book forward of Wave Life Sciences Ltd. – NASDAQ:WVE - TradingView

Jun 26, 2026

Jun 26, 2026

Price to book forward of Wave Life Sciences Ltd. – DUS:1U5 - TradingView

Jun 26, 2026

Jun 26, 2026

Wave Life Sciences (WVE) shareholders approve Singapore Scheme for redomiciliation - Stock Titan

Jun 26, 2026

Jun 26, 2026

We Think Wave Life Sciences (NASDAQ:WVE) Can Afford To Drive Business Growth - Moomoo

Jun 26, 2026

Jun 26, 2026

Price to earnings forward of Wave Life Sciences Ltd. – DUS:1U5 - TradingView

Jun 26, 2026

Jun 25, 2026

Wave Life Sciences(WVE) Stock Options Chain | Quotes & News - Moomoo

Jun 25, 2026

Jun 25, 2026

Wave Life Sciences Ltd. Actuals & Estimates (NASDAQ:WVE) - TradingView

Jun 25, 2026

Jun 25, 2026

WVE Forecast — Price Target — Prediction for 2027 - TradingView

Jun 25, 2026

Jun 25, 2026

Wave Life Sciences initiates phase 2a obesity trial for WVE-007 By Investing.com - Investing.com Australia

Jun 25, 2026

Jun 25, 2026

Wave Life Sciences initiates phase 2a obesity trial for WVE-007 - Investing.com UK

Jun 25, 2026

Jun 24, 2026

Wave Life Sciences Announces Initiation of Phase 2a Portion of INLIGHT Trial of WVE-007 for Obesity and Cardiometabolic Diseases - Investing News Network

Jun 24, 2026

Jun 24, 2026

Wave Life Sciences Ltd. (WVE) stock price, news, quote and history - Yahoo Finance Australia

Jun 24, 2026

Jun 24, 2026

Wave Life Sciences (WVE) Advances Phase 2a Clinical Trial for WV - GuruFocus

Jun 24, 2026

Jun 24, 2026

Wave Life Sciences Starts Phase 2 Trial of Obesity Drug - Moomoo

Jun 24, 2026

Jun 24, 2026

Wave Life Sciences Initiates Phase 2a of INLIGHT Trial of WVE-007 for Obesity, Reporting Sustained Visceral Fat Reduction in Phase 1 Data - Quiver Quantitative

Jun 24, 2026

Jun 24, 2026

Wave Life Sciences Announces Initiation of Phase 2a Portion of INLIGHT™ Trial of WVE-007 (INHBE GalNAc-siRNA) for Obesity and Cardiometabolic Diseases - The Manila Times

Jun 24, 2026

Jun 24, 2026

Wave Life Sciences Announces Initiation of Phase 2a Portion - GlobeNewswire

Jun 24, 2026

Jun 19, 2026

Price-Driven Insight from (WVE) for Rule-Based Strategy - Stock Traders Daily

Jun 19, 2026

Jun 19, 2026

The Bull Case For Wave Life Sciences (WVE) Could Change Following A Zacks Earnings-Estimate Upgrade - simplywall.st

Jun 19, 2026

Jun 18, 2026

WAVE LIFE SCIENCES LTD (WVE) Stock Chart - ChartMill

Jun 18, 2026

Jun 18, 2026

WAVE Life Sciences Ltd (WVE) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Jun 18, 2026

Jun 18, 2026

WAVE Life Sciences Ltd (WVE) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Jun 18, 2026

Jun 18, 2026

WAVE Life Sciences Ltd (WVE) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Jun 18, 2026

Jun 17, 2026

WAVE Life Sciences Ltd (WVE) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Jun 17, 2026

Jun 17, 2026

WAVE Life Sciences Ltd (WVE) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Jun 17, 2026

Jun 17, 2026

WAVE Life Sciences Ltd (WVE) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Jun 17, 2026

Jun 16, 2026

Wave Life Sciences (WVE) Stock Could Be 73% Undervalued After WVE 006 Data - simplywall.st

Jun 16, 2026

Jun 16, 2026

Wave Life Sciences (WVE) Upgraded to Buy: Here's Why - Yahoo Finance

Jun 16, 2026